Determining risks and benefits through proper clinical trials remains highly desired, but these will take considerable time and funds. As a result, clinical data will not appear any time soon, while patients will not simply stop using the many CBD products to which they have become accustomed. Taking back regulatory control over CBD could therefore start with a more short-term and achievable approach, i.e., demanding accurate and proper labeling, reflecting in detail what each product does and does not contain, and how it was manufactured. For a clearer judgment of the potential therapeutic effects, the risks, but also the legality of a cannabis extract, it is important to know its exact composition. After all, published data from around the world has taught us that misleading labels as well as harmful contaminants are real and actual problems for CBD products. The analytical methodology and the third-party labs needed for this approach largely already exist, and could easily be optimized to quickly get a better grip on the unrestrained cannabinoid market. This approach would hold each producer strictly accountable for the quality and safety of their own products, as long as there are real legal consequences for those businesses that break the rules. Add to this a system for regular professional audits and inspections, and a crackdown on unsubstantiated health claims, and we have a reasonable system to ensure that CBD can be used responsibly by those who need it, until much needed clinical data become available.
The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.
Cannabidiol is currently a class B1 controlled drug in New Zealand under the Misuse of Drugs Act. It is also a prescription medicine under the Medicines Act. In 2017 the rules were changed so that anyone wanting to use it could go to the Health Ministry for approval. Prior to this, the only way to obtain a prescription was to seek the personal approval of the Minister of Health.

CBD Oil

×